Research Headlines – Faster access to better and safer medicines
A potential drawback of clinical trials of new drugs is that they do not always reflect how well these will work in the ‘real world’. EU and industry-funded research brought together key stakeholders to help add more such evidence into the design of trials, increasing confidence in new medicines and